Novartis Ag (NVS) Divestments (2013 - 2025)
Novartis Ag recorded quarterly Divestments of -$2.2 billion in Q2 2025, down 779.7% quarter-over-quarter from $330.0 million in Q1 2025, and up 30.06% year-over-year from -$1.7 billion in Q2 2024.
Novartis Ag's Divestments history runs 13 years deep, the most recent figure standing at -$2.2 billion for Q2 2025.
- In Q2 2025, Divestments rose 30.06% year-over-year to -$2.2 billion; the TTM figure through Jun 2025 stood at -$6.0 billion (down 19.14% YoY), while the FY2025 annual figure was -$88.0 million, down 182.24% from the prior year.
- Divestments came in at -$2.2 billion for Q2 2025 at Novartis Ag, down from $330.0 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $877.0 million in Q4 2021 to a low of -$11.6 billion in Q2 2022.
- A 5-year average of -$1.2 billion and a median of -$111.0 million in 2022 frame the typical range for Divestments.
- Across the five-year window, Divestments jumped 43950.0% in 2021 and sank 12087.63% in 2022, its largest moves.
- Novartis Ag's Divestments stood at $877.0 million in 2021, then tumbled by 116.88% to -$148.0 million in 2022, then sank by 398.65% to -$738.0 million in 2023, then plunged by 334.55% to -$3.2 billion in 2024, then jumped by 30.06% to -$2.2 billion in 2025.
- According to Business Quant data, Divestments over the past three periods registered -$2.2 billion, $330.0 million, and -$3.2 billion for Q2 2025, Q1 2025, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 312.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2.24 Bn |
| Mar 31, 2025 | 330.00 Mn |
| Jun 30, 2024 | -3.21 Bn |
| Mar 31, 2024 | -899.00 Mn |
| Dec 31, 2023 | -738.00 Mn |
| Sep 30, 2023 | -208.00 Mn |
| Jun 30, 2023 | -93.00 Mn |
| Mar 31, 2023 | -84.00 Mn |
| Dec 31, 2022 | -148.00 Mn |
| Sep 30, 2022 | -111.00 Mn |
| Jun 30, 2022 | -11.63 Bn |
| Dec 31, 2021 | 877.00 Mn |
| Sep 30, 2021 | 6.00 Mn |
| Jun 30, 2021 | 97.00 Mn |
| Mar 31, 2021 | -5.00 Mn |
| Dec 31, 2020 | -2.00 Mn |
| Sep 30, 2020 | -20.00 Mn |
| Jun 30, 2020 | -91.00 Mn |
| Mar 31, 2020 | -14.00 Mn |
| Dec 31, 2019 | -57.00 Mn |
| Sep 30, 2019 | 3.00 Mn |
| Jun 30, 2019 | -682.00 Mn |
| Mar 31, 2019 | -423.00 Mn |
| Dec 31, 2018 | -543.00 Mn |
| Sep 30, 2018 | -185.00 Mn |
| Jun 30, 2018 | -136.00 Mn |
| Mar 31, 2018 | -137.00 Mn |
| Dec 31, 2017 | -13.00 Mn |
| Sep 30, 2017 | -40.00 Mn |
| Jun 30, 2017 | -40.00 Mn |
| Mar 31, 2017 | -47.00 Mn |
| Dec 31, 2016 | -226.00 Mn |
| Sep 30, 2016 | -63.00 Mn |
| Jun 30, 2016 | -251.00 Mn |
| Mar 31, 2016 | -208.00 Mn |
| Dec 31, 2015 | -213.00 Mn |
| Sep 30, 2015 | -140.00 Mn |
| Jun 30, 2015 | -654.00 |
| Dec 31, 2014 | -132.00 |
| Sep 30, 2014 | -236.00 |
| Jun 30, 2014 | -301.00 |
| Mar 31, 2013 | 696.00 |